Effect of Ultra-low Dose Naloxone on Remifentanil-Induced Hyperalgesia

Stopped Study terminated early due to low enrollment. Only 8 participants enrolled out of the target 105.

Conditions

• Hyperalgesia

Interventions

• DRUG: Remifentanil
• DRUG: Remifentanil+ Placebo
• DRUG: Remifentanil +ultra-low dose naloxone

Sponsor

University of California, Irvine